Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
193,548,280
-
Number of holders
-
249
-
Total 13F shares, excl. options
-
160,423,640
-
Shares change
-
-11,827
-
Total reported value, excl. options
-
$8,584,258,442
-
Value change
-
+$6,378,846
-
Put/Call ratio
-
1.62%
-
Number of buys
-
145
-
Number of sells
-
-114
-
Price
-
$53.52
Significant Holders of INCYTE CORP - COMMON STOCK (INCY) as of Q1 2014
306 filings reported holding INCY - INCYTE CORP - COMMON STOCK as of Q1 2014.
INCYTE CORP - COMMON STOCK (INCY) has 249 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 160,423,640 shares
of 193,548,280 outstanding shares and own 82.89% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (22,322,216 shares), Capital World Investors (17,668,200 shares), BAKER BROS. ADVISORS LP (14,835,559 shares), VANGUARD GROUP INC (8,125,275 shares), WELLINGTON MANAGEMENT CO LLP (7,846,791 shares), JENNISON ASSOCIATES LLC (7,110,504 shares), Winslow Capital Management, LLC (4,366,407 shares), Artisan Partners Limited Partnership (4,225,506 shares), BB BIOTECH AG (4,133,790 shares), and FRANKLIN RESOURCES INC (4,117,500 shares).
This table shows the top 249 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.